elvitegravir

Gilead Sciences: New HIV Drug Put To Question
Bidness, ETC
Wed, 11/11/15 - 09:09 pm
Gilead Sciences
HIV
Genvoya
elvitegravir
cobicistat
emtricitabine
TAF
4 Key FDA Decisions Expected in November and December
24/7 Wall St
Sun, 11/1/15 - 11:18 am
FDA
Androxal
Repros Therapeutics
elvitegravir
cobicistat
emtricitabine
tenofovir alafenamide
OPuS-2
Biocryst
Synergy Pharmaceuticals
plecanatide
FDA rejects two Gilead HIV drugs as standalone products
Reuters
Mon, 04/29/13 - 10:49 am
FDA
HIV
Gilead
cobicistat
elvitegravir
Stribild
Gilead HIV drug as good as Merck's Isentress: study
Reuters
Wed, 07/25/12 - 09:30 am
Gilead
HIV
Merck
Isentress
elvitegravir
Quad
Gilead Reports Non-inferior Data From Phase 3 Study Of Elvitegravir In HIV
NASDAQ.com
Fri, 12/9/11 - 12:02 pm
HIV
Gilead
elvitegravir
It's the Combo That Matters for Gilead
Motley Fool
Fri, 03/25/11 - 09:27 am
Gilead Sciences
Merck
Isentress
elvitegravir
Abbott Laboratories
GILD's Elvitegravir Meets Study Goal
Yahoo/Zacks
Thu, 03/24/11 - 03:06 pm
Gilead Sciences
elvitegravir
HIV
Gilead HIV drug meets study goal
Yahoo/AP
Wed, 03/23/11 - 10:28 am
Gilead Sciences
HIV
elvitegravir